Gut Microbiota-Derived Resveratrol Metabolites, Dihydroresveratrol and Lunularin, Significantly Contribute to the Biological Activities of Resveratrol
Although resveratrol (RES) is barely detectable in the plasma and tissues upon oral consumption, collective evidence reveals that RES presents various bioactivities in vivo, including anti-inflammation and anti-cancer. This paradox necessitates further research on profiling and characterizing the bi...
Main Authors: | Fang Li, Yanhui Han, Xian Wu, Xiaoqiong Cao, Zili Gao, Yue Sun, Minqi Wang, Hang Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2022.912591/full |
Similar Items
-
Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota
by: Justyna Godos, et al.
Published: (2024-03-01) -
Gut Microbiota Composition in Relation to the Metabolism of Oral Administrated Resveratrol
by: Mingfei Yao, et al.
Published: (2022-02-01) -
Deciphering the Anti-obesity Benefits of Resveratrol: The “Gut Microbiota-Adipose Tissue” Axis
by: Liyuan Zhou, et al.
Published: (2019-06-01) -
Exosome-Containing Extracellular Vesicles Contribute to the Transport of Resveratrol Metabolites in the Bloodstream: A Human Pharmacokinetic Study
by: Carlos Eduardo Iglesias-Aguirre, et al.
Published: (2022-09-01) -
Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
by: Zheng-Wei Zhang, et al.
Published: (2021-10-01)